---
title: "Neridronic Acid - Humoral Hypercalcemia Of Malignancy"
sidebar: mydoc_sidebar
permalink: db11620-mesh-c562390-1.html
toc: false 
---


Path ID: `DB11620_MESH_C562390_1`
{% include image.html url="images/db11620-mesh-c562390-1.png" file="db11620-mesh-c562390-1.png" alt="db11620-mesh-c562390-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C053389 | neridronic acid | Drug |
| GO:0045453 | bone resorption | BiologicalProcess |
| HP:0004363 | Abnormal circulating calcium concentration | PhenotypicFeature |
| MESH:C562390 | Humoral hypercalcemia of malignancy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Neridronic Acid | PREVENTS | Bone Resorption |
| Bone Resorption | CORRELATED WITH | Abnormal Circulating Calcium Concentration |
| Abnormal Circulating Calcium Concentration | OCCURS IN | Humoral Hypercalcemia Of Malignancy |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB11620](https://go.drugbank.com/drugs/DB11620)
